Pricing Log in Create free account

Moleculin Biotech, Inc. (MBRX) vs Soligenix Inc. (SNGX)

Moleculin Biotech, Inc. and Soligenix Inc. are both Biotechnology companies. Moleculin Biotech, Inc. and Soligenix Inc. are of similar size ($7.7M and $7.6M). Soligenix Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 10 metrics below, Soligenix Inc. leads on 6 and Moleculin Biotech, Inc. on 4.

Valuation

Metric MBRX SNGX Biotechnology median
P/E 0.03 n/m 8.50
P/S n/m 11.29 9.71
P/B 0.14 0.84 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.19 0.17 0.64
EV/Sales n/m (3.73) 9.21
Earnings yield 4,008.00% (211.20%) (33.15%)
Free cash flow yield (1,600.09%) (174.60%) (25.50%)

Profitability

Metric MBRX SNGX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,471.05%) (241.65%) (56.36%)
Return on assets (152.41%) (125.95%) (48.04%)
Return on invested capital (417.27%) 0.00% 0.00%

Growth

Metric MBRX SNGX Biotechnology median
Revenue growth (TTM) — (50.37%) 6.02%
EPS growth (last fiscal year) 82.01% 57.03% 30.26%
Revenue growth, 5-year CAGR — (51.88%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBRX SNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.94 2.77 4.72
Net debt to EBITDA 0.35 0.67 0.96

Dividend

Metric MBRX SNGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MBRX SNGX Biotechnology median
Market cap 7.55m 7.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack